Cargando…

Total cholesterol, alanine aminotransferase and the risk of primary liver cancer: A population-based prospective study

Previous studies have shown that serum total cholesterol (TC) and serum alanine aminotransferase (ALT) are associated with liver cancer risk. However, the common contribution of TC and normal-high ALT to primary liver cancer (PLC) has not been reported. We aim to assess the separate and joint effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Miaomiao, Wang, Wanchao, Liu, Xining, Wang, Yiming, Cui, Haozhe, Liu, Siqing, Cao, Liying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104288/
https://www.ncbi.nlm.nih.gov/pubmed/33950959
http://dx.doi.org/10.1097/MD.0000000000025746
_version_ 1783689463558307840
author Sun, Miaomiao
Wang, Wanchao
Liu, Xining
Wang, Yiming
Cui, Haozhe
Liu, Siqing
Cao, Liying
author_facet Sun, Miaomiao
Wang, Wanchao
Liu, Xining
Wang, Yiming
Cui, Haozhe
Liu, Siqing
Cao, Liying
author_sort Sun, Miaomiao
collection PubMed
description Previous studies have shown that serum total cholesterol (TC) and serum alanine aminotransferase (ALT) are associated with liver cancer risk. However, the common contribution of TC and normal-high ALT to primary liver cancer (PLC) has not been reported. We aim to assess the separate and joint effect of low TC level and normal-high ALT level on the risk of PLC, a large prospective cohort was conducted in our study. The participants were divided into 4 groups via the cross-matching method according to TC [low level (−)/non-low level (+)] and ALT [normal level (−)/normal-high level(+)] status, and using the lower quartile value of TC and the upper quartile value of ALT as a threshold, respectively. Incident PLC was confirmed by review of medical records. Cox proportional hazards regression models and interactive additive models were used to evaluate whether the joint effect of low TC level and normal-high ALT level is associated with the risk of PLC. During 1,248,895 person-years follow-up, 298 participants were diagnosed with PLC among 114,972 subjects. In male population, TC < 4.24 mmol/L was group “TC (−)”; TC ≥ 4.24 mmol/L was group “TC (+)”; ALT < 23 U/L was group “ALT (−)”: 33 U/L ≥ ALT ≥ 23 U/L was group “ALT (+)”. Compared with the group “TC (+)”, group “ALT (−)”, respectively, the adjusted hazard ratio (HR) and 95% confidence interval (95%CI) for PLC risk was 1.74 (1.36–2.25) in group “TC (−)” and 1.49 (1.15–1.94) in group “ALT (+)”. In combinatorial analysis, compared with group “TC (+) and ALT (−)”, the significant increased risk of PLC were observed in group “TC (+) and ALT (+)” (HR = 1.41; 95% confidence intervals [CI]: 1.02–1.95), group “TC (−) and ALT (−)” (HR = 1.67; 95%CI: 1.24–2.27) and group “TC (−) and ALT (+)” (HR = 2.72; 95%CI: 1.81–4.09), respectively. However, no statistical significance was found among female. The separate and joint effect of low TC level and normal-high ALT level was observed for PLC risk in males. When combined, individuals with coexistence of low TC level and normal-high ALT level significantly increase the risk of PLC.
format Online
Article
Text
id pubmed-8104288
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-81042882021-05-10 Total cholesterol, alanine aminotransferase and the risk of primary liver cancer: A population-based prospective study Sun, Miaomiao Wang, Wanchao Liu, Xining Wang, Yiming Cui, Haozhe Liu, Siqing Cao, Liying Medicine (Baltimore) 4500 Previous studies have shown that serum total cholesterol (TC) and serum alanine aminotransferase (ALT) are associated with liver cancer risk. However, the common contribution of TC and normal-high ALT to primary liver cancer (PLC) has not been reported. We aim to assess the separate and joint effect of low TC level and normal-high ALT level on the risk of PLC, a large prospective cohort was conducted in our study. The participants were divided into 4 groups via the cross-matching method according to TC [low level (−)/non-low level (+)] and ALT [normal level (−)/normal-high level(+)] status, and using the lower quartile value of TC and the upper quartile value of ALT as a threshold, respectively. Incident PLC was confirmed by review of medical records. Cox proportional hazards regression models and interactive additive models were used to evaluate whether the joint effect of low TC level and normal-high ALT level is associated with the risk of PLC. During 1,248,895 person-years follow-up, 298 participants were diagnosed with PLC among 114,972 subjects. In male population, TC < 4.24 mmol/L was group “TC (−)”; TC ≥ 4.24 mmol/L was group “TC (+)”; ALT < 23 U/L was group “ALT (−)”: 33 U/L ≥ ALT ≥ 23 U/L was group “ALT (+)”. Compared with the group “TC (+)”, group “ALT (−)”, respectively, the adjusted hazard ratio (HR) and 95% confidence interval (95%CI) for PLC risk was 1.74 (1.36–2.25) in group “TC (−)” and 1.49 (1.15–1.94) in group “ALT (+)”. In combinatorial analysis, compared with group “TC (+) and ALT (−)”, the significant increased risk of PLC were observed in group “TC (+) and ALT (+)” (HR = 1.41; 95% confidence intervals [CI]: 1.02–1.95), group “TC (−) and ALT (−)” (HR = 1.67; 95%CI: 1.24–2.27) and group “TC (−) and ALT (+)” (HR = 2.72; 95%CI: 1.81–4.09), respectively. However, no statistical significance was found among female. The separate and joint effect of low TC level and normal-high ALT level was observed for PLC risk in males. When combined, individuals with coexistence of low TC level and normal-high ALT level significantly increase the risk of PLC. Lippincott Williams & Wilkins 2021-05-07 /pmc/articles/PMC8104288/ /pubmed/33950959 http://dx.doi.org/10.1097/MD.0000000000025746 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle 4500
Sun, Miaomiao
Wang, Wanchao
Liu, Xining
Wang, Yiming
Cui, Haozhe
Liu, Siqing
Cao, Liying
Total cholesterol, alanine aminotransferase and the risk of primary liver cancer: A population-based prospective study
title Total cholesterol, alanine aminotransferase and the risk of primary liver cancer: A population-based prospective study
title_full Total cholesterol, alanine aminotransferase and the risk of primary liver cancer: A population-based prospective study
title_fullStr Total cholesterol, alanine aminotransferase and the risk of primary liver cancer: A population-based prospective study
title_full_unstemmed Total cholesterol, alanine aminotransferase and the risk of primary liver cancer: A population-based prospective study
title_short Total cholesterol, alanine aminotransferase and the risk of primary liver cancer: A population-based prospective study
title_sort total cholesterol, alanine aminotransferase and the risk of primary liver cancer: a population-based prospective study
topic 4500
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104288/
https://www.ncbi.nlm.nih.gov/pubmed/33950959
http://dx.doi.org/10.1097/MD.0000000000025746
work_keys_str_mv AT sunmiaomiao totalcholesterolalanineaminotransferaseandtheriskofprimarylivercancerapopulationbasedprospectivestudy
AT wangwanchao totalcholesterolalanineaminotransferaseandtheriskofprimarylivercancerapopulationbasedprospectivestudy
AT liuxining totalcholesterolalanineaminotransferaseandtheriskofprimarylivercancerapopulationbasedprospectivestudy
AT wangyiming totalcholesterolalanineaminotransferaseandtheriskofprimarylivercancerapopulationbasedprospectivestudy
AT cuihaozhe totalcholesterolalanineaminotransferaseandtheriskofprimarylivercancerapopulationbasedprospectivestudy
AT liusiqing totalcholesterolalanineaminotransferaseandtheriskofprimarylivercancerapopulationbasedprospectivestudy
AT caoliying totalcholesterolalanineaminotransferaseandtheriskofprimarylivercancerapopulationbasedprospectivestudy